BioInvent Interim Report 1 January – 31 March 2016

April 26, 2016 |

1 min read

LUND, Sweden--(BUSINESS WIRE)--Regulatory News:

BioInvent (STO:BINV)

Strong financial position and go-ahead for launch of two clinical trials First quarter 2016, January – March 2016

· Net sales for January - March 2016 amounted to SEK 29 (0.6) million.

Earnings Europe

MORE ON THIS TOPIC

Hands in black and white dropping a collection of pills on a pink background

Manufacturing

Viking Secures 1B Supply of Obesity Pill Candidate With $150M Prepayment Deal

March 11, 2025

·

2 min read

·

Annalee Armstrong

Dollar banknote cut into pieces on a yellow background

Gene therapy

Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit

March 11, 2025

·

2 min read

·

Tristan Manalac

Trendy halftone collage. Concept of contracting, negotiation, contracting, favorable terms. Trendy modern retro illustration on business theme. Concept of teamwork. Vector illustration

Mergers & acquisitions

BMS Buys Abecma Partner 2seventy for $286M, Ending Cost Sharing Agreement

March 11, 2025

·

3 min read

·

Tristan Manalac

Composite photo collage of hand hold magnifier glass research examine secret object question mark secret isolated on painted background.

Editorial

This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency

March 7, 2025

·

3 min read

·

Annalee Armstrong